16709661

Source:http://linkedlifedata.com/resource/pubmed/id/16709661

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0030705, umls-concept:C0035525, umls-concept:C0205156, umls-concept:C0231175, umls-concept:C0279030, umls-concept:C0391001, umls-concept:C0524910
pubmed:issue	11
pubmed:dateCreated	2006-10-18
pubmed:abstractText	The management of patients with chronic hepatitis C who have relapsed or failed to respond to interferon based therapies is an important issue facing hepatologists.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-10349693, http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-10365827, http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-11357217, http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-11583749, http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-12324553, http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-12407572, http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-12407586, http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-12407593, http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-12753338, http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-12939591, http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-14996676, http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-14996679, http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-15057741, http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-15282351, http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-15359210, http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-16082735, http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-16422999, http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-9807989, http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-9819446, http://linkedlifedata.com/resource/pubmed/commentcorrection/16709661-9819447
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2985108R
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin, http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2a, http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2a
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	0017-5749
pubmed:author	pubmed-author:AndersonFF, pubmed-author:BainV GVG, pubmed-author:BalshawRR, pubmed-author:Canadian Pegasys Study Group, pubmed-author:DeschenesMM, pubmed-author:KaitaKK, pubmed-author:KrajdenMM, pubmed-author:LeeS SSS, pubmed-author:PeltekianKK, pubmed-author:ShermanMM, pubmed-author:SimonyiSS, pubmed-author:YoshidaE MEM
pubmed:issnType	Print
pubmed:volume	55
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1631-8
pubmed:dateRevised	2011-11-17
pubmed:meshHeading	pubmed-meshheading:16709661-Adult, pubmed-meshheading:16709661-Antiviral Agents, pubmed-meshheading:16709661-Drug Therapy, Combination, pubmed-meshheading:16709661-Female, pubmed-meshheading:16709661-Hepatitis C, Chronic, pubmed-meshheading:16709661-Humans, pubmed-meshheading:16709661-Interferon-alpha, pubmed-meshheading:16709661-Male, pubmed-meshheading:16709661-Middle Aged, pubmed-meshheading:16709661-Patient Dropouts, pubmed-meshheading:16709661-Polyethylene Glycols, pubmed-meshheading:16709661-Recombinant Proteins, pubmed-meshheading:16709661-Ribavirin, pubmed-meshheading:16709661-Treatment Failure, pubmed-meshheading:16709661-Treatment Outcome
pubmed:year	2006
pubmed:articleTitle	Peginterferon alfa-2a (40KD) plus ribavirin in chronic hepatitis C patients who failed previous interferon therapy.
pubmed:affiliation	Toronto General Hospital, 200 Elizabeth St, Toronto, Ontario, M5G 2C4 Canada. morris.sherman@uhn.on.ca
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, Non-U.S. Gov't, Multicenter Study